A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers

NCT03013881 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

BIOLOGICAL: UB-921
BIOLOGICAL: Herceptin

Sponsor

United BioPharma

Collaborators

[object Object]